Pranay belongs to the small group of writers and thinkers with an aptitude for and experience in both business and philosophy. He was admitted to Oxford at the age of 15, graduated at 18 to become a commodities trader, and then returned to academia five years later to begin a research and teaching career as a philosopher. He now works as a philosophical consultant to business and a writer and editor. Pranay’s areas of expertise include intergenerational justice, with a particular focus on how changes in technology and society alter what it means to be human, and the practical application of philosophy to life and business. His work includes an edited volume on justice and climate change for Cambridge University Press, parts of the UN IPCC’s 5th Assessment Report, and many articles for leading non-academic publications. A passionate cricket fan, he also writes about the sport as a correspondent for ESPN.
Paul is a bestselling and award-winning writer and editor with more than twenty years of research, writing, and editorial experience. His commercial writing work spans a wide range of genres, with an emphasis on thought leadership, organizational leadership, technology, and healthcare. In the last five years, Paul’s projects have been serialized in a major national newspaper, reached the Amazon non-fiction Top 10, and been awarded the British Medical Association’s Psychiatry Book of the Year award. Paul trained as an academic historian of philosophy and spent fifteen years teaching and researching at leading universities in Europe, the U.S., and Asia. His research on Stoic and Platonic thought has been published by the leading academic presses in the world (including both Oxford and Cambridge University Presses), and he continues to work as a writing coach and editor for senior historians and scientists. Paul is an honorary fellow in the Faculty of Humanities and Social Sciences at the University of Liverpool.
Faisal Hoque is recognized as one of the world’s leading management thinkers and technologists. He is an award-winning entrepreneur, innovator, and a #1 Wall Street Journal best-selling author with close to 30 years of cross-industry success. He is the founder of SHADOKA, NextChapter, and other companies. He also serves as an innovation leader for CACI, an $8B company focused on US national security.
As a founder and CEO of multiple companies, he is a three-time winner of Deloitte Technology Fast 50™ and Fast 500™ awards. He has developed more than 20 commercial platforms and worked with leadership of US DoD, DHS, GE, MasterCard, American Express, Home Depot, PepsiCo, IBM, Chase, and others. Faisal is a three-time Wall Street Journal bestselling author for his books: REINVENT (#1), Everything Connects (#2), and LIFT (#1).
Faisal has authored 10 award-winning books (published by Cambridge University Press, the Financial Times, HarperCollins Leadership, McGraw Hill, Fast Company Press, and others). His more than thirty awards include Axiom Gold, Nautilus, Foreword, Book Excellence, 2023 Thinkers50 Distinguished Achievement Awards Shortlist, and others in the fields of humanity, business, and technology. He volunteers for several organizations, including MIT IDEAS Social Innovation Program. He is also a contributor at the Swiss business school IMD, Thinkers50, Project Management Institute (PMI), and others.
He has been named among the Top 100 Most Influential People in Technology by the editors of Ziff-Davis Enterprise and Trust Across America-Trust Around the World (TAA-TWA) named him one of the Top 100 Thought Leaders. His work has appeared in Fast Company, Business Insider, Wall Street Journal, BusinessWeek, Fox, CBS, Financial Times, Forbes, Inc., and others.
Faisal frequently speaks at international conferences, business schools, corporate gatherings, and business summits. His talks focus on leadership, innovation, and transformation with a particular emphasis on long-term sustainable impact. Inspired by his personal experiences, Faisal is also a passionate advocate for cancer research, raising awareness and supporting research efforts to combat the disease.